×
×

Top Pharma Companies in India as on Mar-2025

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?


×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
698.504.13%
1,598.554.05%
2,489.803.86%
474.703.23%
1,099.503.07%

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
1,253.90-6.40%
281.50-5.38%
146.65-4.68%
339.80-3.70%
16.45-3.18%

News about Top Pharma Companies in India

Glenmark Pharmaceuticals informs about disclosure

Glenmark Pharmaceuticals has informed that IGI Inc., wholly owned subsidiary of Glenmark Pharmaceuticals (the Company) has announced its plans to cease all CMC development and clinical supplies manufacturing at its facility in La Chaux-de-Fonds, Switzerland. In accordance with the Listing Regulations and SEBI Circular No SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, regarding the disclosure by listed entities under Regulation 30 of the Listing Regulations, we are providing the details of the intended closure of the aforementioned manufacturing facility herein below: Date of such binding agreement, if any, entered for sale of such unit/division, if any - Not Applicable ; Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year – Turnover of plant - Rs. NIL (material is only used for captive consumption) Percentage to consolidated turnover of Company (1 April 2023 to 31 March 2024): NA Net worth of plant - Rs. 223.52 million (as of 31 March 2024); Estimated date of closure - 31 July 2025; Reasons for closure - IGI is progressing its pipeline and it is anticipated that higher quantities of finished product will be required for future clinical programs. IGI CMC development and manufacturing of ongoing and future clinical programs will be moved to a network of well-established Contract Development and Manufacturing Organizations (CDMOs); This closure will not adversely affect the Consolidated financials of the Company.

The above information is a part of company’s filings submitted to BSE.

29 Mar, 2025

GlaxoSmithKline Pharmaceuticals informs about postal ballot notice

GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of Postal Ballot Notice pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which is being sent to the Members of the Company, seeking their approval for re-appointment of Juby Chandy as a Whole-time Director & Chief Financial Officer & Appointment of Somasundaram Palamadairamaswamy & Anup Wadhawan as an Independent Directors. In compliance with the Circulars of the Ministry of Corporate Affairs, the said Notice is being sent electronically only to those Members, whose names appear in the Register of Members/ List of Beneficial Owners as received from National Securities Depository (‘NSDL’)/ Central Depository Services (India) (‘CDSL’) and who have registered their e-mail addresses in respect of electronic holdings with NSDL/CDSL through the concerned Depository Participants and in respect of physical holdings with the Company’s Registrar and Share Transfer Agent (RTA) i.e. KFin Technologies (‘KFintech’) as on Friday, 21st March, 2025 (cut-off date). The e-voting shall commence on Monday, 31st March, 2025 at 09.00 am (IIST) till Tuesday, 29th April 2025 at 5.00 PM (IST). The copy of the said Notice is also available on the website of the Company at https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ and on the website of Kfintech https://evoting.kfintech.com/.

The above information is a part of company’s filings submitted to BSE.

28 Mar, 2025

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2025.

Rank Company Market Capitalization 2025 (INR  crores)
1 Sun Pharmaceutical Industries Ltd. 4,16,393 Crore
2 Divis Laboratories Ltd. 1,53,258 Crore
3 Cipla Ltd. 1,16,434 Crore
4 Torrent Pharmaceuticals Ltd. 1,09,474 Crore
5 Max Healthcare Institute Ltd. 1,06,615 Crore
6 Mankind Pharma Ltd. 99,974 Crore
7 Dr. Reddys Laboratories Ltd. 95,466 Crore
8 Apollo Hospitals Enterprise Ltd. 95,219 Crore
9 Lupin Ltd. 92,523 Crore
10 Zydus Lifesciences Ltd. 89,122 Crore
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (M) Very Good 30,731 65,300 48.93 16.82 34.21 34.87
Natco Pharma Ltd. (S) Very Good 797.7 14,288 7.66 1.96 5.22 25.73
Torrent Pharmaceuticals Ltd. (L) Very Good 3,235 1,09,474 58.79 13.67 30.00 24.28
Ajanta Pharma Ltd. (S) Very Good 2,619 32,708 36.43 8.37 24.14 23.04
Dr. Reddys Laboratories Ltd. (L) Very Good 1,144 95,466 17.77 2.97 10.69 21.33

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Divis Laboratories Ltd. (L) Very Good 5,773 1,53,258 67.98
Glenmark Pharmaceuticals Ltd. (M) Somewhat Good 1,540 43,458 60.84
Laurus Labs Ltd. (S) Very Good 616.8 33,099 56.68
Biocon Ltd. (M) Somewhat Good 341.2 40,964 29.19
Lupin Ltd. (M) Somewhat Good 2,027 92,523 25.26
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Mankind Pharma Ltd. (M) Very Good 2,446 99,974 51.08 7.04 33.55 19.33
Laurus Labs Ltd. (S) Very Good 616.8 33,099 165.3 7.84 39.26 17.07
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,622 25,254 40.18 7.62 24.80 17.05
Ajanta Pharma Ltd. (S) Very Good 2,619 32,708 36.43 8.37 24.14 15.41
Gland Pharma Ltd. (S) Very Good 1,614 26,233 23.40 2.77 13.99 15.31

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Lupin Ltd. (M) Somewhat Good 2,027 92,523 32.25 5.61 18.39 36.90
Biocon Ltd. (M) Somewhat Good 341.2 40,964 68.04 3.57 111.7 31.80
Mankind Pharma Ltd. (M) Very Good 2,446 99,974 51.08 7.04 33.55 29.77
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,622 25,254 40.18 7.62 24.80 26.08
Granules India Ltd. (S) Very Good 487.1 11,814 36.63 3.58 19.14 24.68
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...